☰

Kathryn T. Bieging, Ph.D. - Publications

Affiliations: 
2010 Integrated Graduate Program in the Life Sciences Northwestern University, Evanston, IL 
Area:
Virology Biology, Oncology
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Incrocci R, Hussain S, Stone A, Bieging K, Alt LA, Fay MJ, Swanson-Mungerson M. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation. Cellular Immunology. PMID 26255694 DOI: 10.1016/J.Cellimm.2015.08.001  0.425
2015 Bieging KT, Attardi LD. A piece of the p53 puzzle Nature. 520: 37-38. PMID 25799989 DOI: 10.1038/Nature14374  0.398
2015 Jiang D, LaGory EL, Kenzelmann Brož D, Bieging KT, Brady CA, Link N, Abrams JM, Giaccia AJ, Attardi LD. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function. Cell Reports. 10: 1096-109. PMID 25704813 DOI: 10.1016/J.Celrep.2015.01.043  0.467
2014 Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression Nature Reviews Cancer. 14: 359-370. PMID 24739573 DOI: 10.1038/Nrc3711  0.395
2013 Kenzelmann Broz D, Mello SS, Bieging KT, Jiang D, Dusek RL, Brady CA, Sidow A, Attardi LD. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses Genes and Development. 27: 1016-1031. PMID 23651856 DOI: 10.1101/Gad.212282.112  0.456
2013 Brägelmann J, Dagogo-Jack I, El Dinali M, Stricker T, Brown CD, Zuo Z, Khattri A, Keck M, McNerney ME, Longnecker R, Bieging K, Kocherginsky M, Alexander K, Salgia R, Lingen MW, et al. Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncology. 49: 525-33. PMID 23490885 DOI: 10.1016/J.Oraloncology.2013.02.003  0.502
2013 Brady CA, Broz DK, Jiang D, Mello SS, Bieging K, Johnson TM, Jarvis LA, Kozak MM, Basak S, Attardi LD. Abstract IA4: Deconstructing p53 pathways in vivo Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Ia4  0.491
2012 Bieging KT, Attardi LD. Deconstructing p53 transcriptional networks in tumor suppression Trends in Cell Biology. 22: 97-106. PMID 22154076 DOI: 10.1016/J.Tcb.2011.10.006  0.538
2011 Bieging KT, Fish K, Bondada S, Longnecker R. A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma. Blood. 118: 6849-59. PMID 22039254 DOI: 10.1182/Blood-2011-02-338434  0.582
2010 Bieging KT, Swanson-Mungerson M, Amick AC, Longnecker R. Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A. Cell Cycle (Georgetown, Tex.). 9: 901-8. PMID 20160479 DOI: 10.4161/Cc.9.5.10840  0.608
2009 Bieging KT, Amick AC, Longnecker R. Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 17945-50. PMID 19815507 DOI: 10.1073/Pnas.0907994106  0.633
2009 Bieging KT, Amick AC, Longnecker R. Abstract B30: EBV LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-B30  0.571
Show low-probability matches.